Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Start Date
4/29/2021
Completion Date
12/30/2029
Summary
This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.
Detailed Description
This study is intended to evaluate the post-operative complications and recurrence following the use of OviTex in ventral or inguinal hernias being treated robotically. It is a single-arm study and all subjects will receive OviTex.
Eligibility Criteria
Age Range: 21 years to No maximum
Interventions
OviTex Reinforced Tissue Matrix
Conditions
Locations
University of South Alabama
Mobile, Alabama 36617
United States
SurgOne
Denver, Colorado 802210
United States
GenesisCare
Destin, Florida 325541
United States
Surgical Healing Arts Center
Fort Myers, Florida 33912
United States
St. Luke's Hospital
Overland Park, Kansas 66213
United States
University of Louisville
Louisville, Kentucky 40202
United States
Munson Healthcare
Traverse City, Michigan 49684
United States
St. Francis Hospital
Roslyn, New York 11576
United States
Mohawk Valley Health System
Utica, New York 13502
United States
Houston Methodist
Houston, Texas 77030
United States